What does Bright Minds Biosciences Inc. do?
Bright Minds Biosciences Inc., a biotechnology company, develops therapeutics to improve the lives of patients with severe and life-altering diseases in the United States. Its portfolio includes 5-HT2 Receptors, which are serotonin agonists for epilepsy and neuropsychiatric disorders; and BMB-101, which has completed…
What is Bright Minds Biosciences Inc.'s P/E and P/B ratio?
Bright Minds Biosciences Inc. has a P/E ratio of -25.7 and a P/B ratio of 2.37.
What is Bright Minds Biosciences Inc.'s debt-to-equity ratio?
Bright Minds Biosciences Inc. has a debt-to-equity ratio of 0.00.
How much does Bright Minds Biosciences Inc. owe compared with what it owns?
Bright Minds Biosciences Inc. owes C$0.01 for every C$1 it owns (balance sheet Jun 2026), which is low.
What is Bright Minds Biosciences Inc.'s Positivity rank?
Bright Minds Biosciences Inc. is ranked #2,839 of 6,775 companies globally and #1,003 of 4,000 in United States on PositoAI, with a Positivity Score of 21,138.
Does Bright Minds Biosciences Inc. have any regulatory orders, red flags (PosiRed) or yellow flags (PosiYellow)?
No active red flags (PosiRed) or yellow flags (PosiYellow) are currently on record for Bright Minds Biosciences Inc..
Where can I read the latest news about Bright Minds Biosciences Inc.?
Recent headlines about Bright Minds Biosciences Inc. from the last 30 days, with links to the original articles, are on its News page on PositoAI.
Does Bright Minds Biosciences Inc. have a PositoAI PosiShot or QR code?
Yes. A dated PosiShot of Bright Minds Biosciences Inc.'s current position, a PosiQR code for its live profile and a ready-made dated mention are available on its For this company page on PositoAI.